{
    "2021-05-24": [
        [
            {
                "time": "",
                "original_text": "甘李药业精蛋白人胰岛素混合注射液获批上市",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "精蛋白人胰岛素",
                        "混合注射液",
                        "获批",
                        "上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业(603087.SH) ：获得一款预混胰岛素的药品注册批件",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "603087.SH",
                        "预混胰岛素",
                        "药品注册批件"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}